| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0008 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | 0.74 | 0.001 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.098 | 0.002 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.003 |